Transurethral<unk><unk>  (also called<unk>  or transurethral radiofrequency<unk>  is a technique that uses low energy radio frequency delivered through two<unk> s to ablate excess prostate tissue. A cystoscope/catheter deploys the<unk> s toward the obstructing prostate tissue is inserted into the urethra directly through the penis under local anesthetic before the procedure begins. The energy from the probe heats the abnormal prostate tissue without damaging the urethra. The resulting scar tissue later atrophies, reducing the size of the prostate which in turn reduces the constriction of the urethra. It can be done with a local anesthetic on an outpatient basis. It takes about an hour to perform the procedure. It takes about 30 days for the ablated prostate tissue to resorb. Transurethral<unk><unk>  can be used to treat benign prostatic hyperplasia (BPH). Some clinical studies have reported that<unk>  is safe and effective, improving the urine flow with minimal side effects when compared with other procedures, such as transurethral resection of the prostate (TURP) and open prostatectomy. However, other studies have reported that the procedure has a high failure rate, with the majority of patients requiring retreatment. Some patients have reported long-term inflammation of their prostate after undergoing the<unk>  process. This is known as chronic prostatitis.
Transurethral needle ablation of the prostate
Transurethral resection of the prostate
Transurethral incision of the prostate
Prostatic artery embolization
Active surveillance of prostate cancer
Laparoscopic radical prostatectomy
Prostatic stent
Transurethral microwave thermotherapy